You have 9 free searches left this month | for more free features.

Fibrosis

Showing 8451 - 8475 of 9,526

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lupus Erythematosus, Systemic Trial in Worldwide (Placebo, MEDI-570 0.03 MG, MEDI-570 0.1 MG)

Terminated
  • Lupus Erythematosus, Systemic
  • Placebo
  • +4 more
  • Long Beach, California
  • +16 more
Aug 11, 2014

Adverse Reactions to MR and CT-examinations

Completed
  • Renal Adverse Events - Contrast Induced Nephropathy (CIN)
  • Non-renal Adverse Events
    • Herlev, Denmark
      Department of Diagnostic Radiology,Copenhagen University Hospita
    Jan 25, 2014

    Chemotherapeutic Agent Toxicity, Mucositis, Radiation Toxicity Trial in Buffalo, Hamilton (dietary supplement, other, drug,

    Terminated
    • Chemotherapeutic Agent Toxicity
    • +15 more
    • selenomethionine
    • +4 more
    • Buffalo, New York
    • +1 more
    Aug 8, 2014

    Humira® in Psoriatic Arthritis in Normal Medical Practice

    Completed
    • Psoriatic Arthritis
      • Aachen, Germany
      • +508 more
      Dec 29, 2014

      Fatty Liver Trial in Sao Paulo (Omega 3)

      Completed
      • Fatty Liver
      • Omega 3
      • Sao Paulo, Brazil
        University of Sao Paulo School of Medicine
      Nov 19, 2013

      Skin Fibrosis Trial in Worldwide (P144, )

      Completed
      • Skin Fibrosis
      • Bad Nauheim, Hesse, Germany
      • +16 more
      Feb 8, 2013

      Cystic Fibrosis Trial in Canada, United States (7% Hypertonic Saline (HS), 0.9% Isotonic Saline (IS))

      Completed
      • Cystic Fibrosis
      • 7% Hypertonic Saline (HS)
      • 0.9% Isotonic Saline (IS)
      • Birmingham, Alabama
      • +29 more
      Feb 11, 2013

      NSCLC Trial in Worldwide (erlotinib [Tarceva], Placebo)

      Completed
      • Non-Small Cell Lung Cancer
      • erlotinib [Tarceva]
      • Placebo
      • St. Leonards, New South Wales, Australia
      • +132 more
      Jan 27, 2015

      Chronic Hepatitis C Trial in Madrid (Ribavirin, Colchicine)

      Terminated
      • Chronic Hepatitis C
      • Madrid, Spain
      • +2 more
      Jan 30, 2013

      Posthepatitic Cirrhosis Trial in Shanghai (Fuzheng Huayu Tablets, sham Fuzheng Huayu Tablets ())

      Completed
      • Posthepatitic Cirrhosis
      • Fuzheng Huayu Tablets
      • sham Fuzheng Huayu Tablets (placebo)
      • Shanghai, China
        Shuguang Hospital
      Mar 6, 2013

      Nonsquamous Non-Small Cell Tumor of Lung, NSCLC Metastatic, NSCLC Stage IIIB Trial in Sweden, United Kingdom (Pemetrexed)

      Completed
      • Nonsquamous Non-Small Cell Neoplasm of Lung
      • +2 more
      • Linkoping, Sweden
      • +8 more
      Oct 3, 2014

      Chronic Myelomonocytic Leukemia, Essential Thrombocythemia, Polycythemia Vera Trial in Chicago (imatinib mesylate, laboratory

      Completed
      • Chronic Myelomonocytic Leukemia
      • +3 more
      • imatinib mesylate
      • laboratory biomarker analysis
      • Chicago, Illinois
        University of Chicago
      Feb 24, 2014

      Hepatocellular Carcinoma, Fibrolamellar Hepatocellular Carcinoma Trial in Clichy (Sutent)

      Terminated
      • Hepatocellular Carcinoma
      • Fibrolamellar Hepatocellular Carcinoma
      • Clichy, Hauts de Seine, France
        Hôpital Beaujon
      Mar 12, 2014

      Cystic Fibrosis Trial in Stockholm (Lung function test)

      Completed
      • Cystic Fibrosis
      • Lung function test
      • Stockholm, Sweden
        Karolinska University Hospital
      Nov 29, 2012

      Venous Thromboembolism Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939), Enoxaparin, Placebo: tablet of Rivaroxaban)

      Completed
      • Venous Thromboembolism
      • Rivaroxaban (Xarelto, BAY59-7939)
      • +3 more
      • Birmingham, Alabama
      • +123 more
      Oct 28, 2014

      Lymphoma Trial in Canada, United States (IV Busulfan, Cyclophosphamide and Etoposide (BuCyE Regimen))

      Completed
      • Lymphoma
      • IV Busulfan, Cyclophosphamide and Etoposide (BuCyE Regimen)
      • Birmingham, Alabama
      • +41 more
      Jul 1, 2014

      Disease Progression in Chronic Hepatitis C

      Active, not recruiting
      • Hepatitis C, Chronic
      • +2 more
        • (no location specified)
        Dec 13, 2013

        Health Subjects With Cardiovascular Risk Factors Trial in Milan (L-GSH, Placebo)

        Completed
        • Health Subjects With Cardiovascular Risk Factors
        • L-GSH
        • Placebo
        • Milan, Italy
          Oberdan Parodi, MD
        May 7, 2014

        Diastolic Heart Failure Trial (aldactone)

        Completed
        • Diastolic Heart Failure
        • (no location specified)
        Sep 12, 2013

        Etanercept in Patients Treated Over Long-term in Real-world

        Completed
        • Rheumatoid Arthritis
        • (no location specified)
        Jul 7, 2014

        Cystic Fibrosis, Pseudomonas Aeruginosa Trial in Canada (Aztreonam lysine)

        Approved for marketing
        • Cystic Fibrosis
        • Pseudomonas Aeruginosa
        • Aztreonam lysine
        • Calgary, Alberta, Canada
        • +3 more
        Dec 12, 2012

        Cystic Fibrosis With Mild to Moderate Lung Disease, CMRI of Lung Perfusion, Lung Perfusion Trial (Sildenafil)

        Withdrawn
        • Cystic Fibrosis With Mild to Moderate Lung Disease
        • +3 more
        • (no location specified)
        Dec 10, 2012

        Cirrhosis Trial in Caen (L-carnitine, Lactulose)

        Completed
        • Cirrhosis
        • Caen, France
          University Hospital of Caen
        Feb 26, 2013

        CYSTIC FIBROSIS Trial in Roma (Lactobacillus reuteri, )

        Completed
        • CYSTIC FIBROSIS
        • Lactobacillus reuteri
        • placebo
        • Roma, Italy
          Dipartimento di pediatria e neuropsichiatria Policlinico Umberto
        Nov 28, 2012